The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anti-cancer drugs: Its importance to solid tumour chemotherapy

Journal of Neuro-Oncology

Volumn 31, Issue 1-2, 1997, Pages 195-207

  El Alaoui, Said ^a   Lawry, John ^b   Griffin, Martin ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Anticancer drugs; Apoptosis; Cell cycle; Hamster fibrosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; FLUOROURACIL; HYDROXYUREA; IONOMYCIN; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DESIGN; DRUG SENSITIVITY; FIBROSARCOMA; FLOW CYTOMETRY; HAMSTER; NONHUMAN; SOLID TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL COUNT; CELL CYCLE; CRICETINAE; DNA, NEOPLASM; ELECTROPHORESIS, AGAR GEL; FIBROSARCOMA; FLOW CYTOMETRY; TUMOR CELLS, CULTURED;

EID: 0031040172     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005782708570     Document Type: Article

References (25)

1. Dive C, Hickmann JA: Drug target interactions: only the first step in the commitment to a programmed cell death. Br J Cancer 64: 192-196, 1991
2. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-139, 1992
3. Hill BT: The cell cycle and its significance for cancer treatment. Cancer Treat Rev 2: 159-175, 1975
4. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Brit J Cancer 26: 239-257, 1972
5. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980
6. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z: The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumour agents. Cancer Res 53: 3186-3192, 1993
7. Cotter TG, Glynn JM, Echeverri F, Green DR: The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res 12: 773-780, 1992
8. El Alaoui S, Mian S, Lawry J, Quash G, Griffin M: Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis). FEBS Lett 2: 174-178, 1992
9. Pratt NR, Lowther GW, Rees RC, Teale DM, Potter CW: Non random chromosome changes in a herpes-virus-transformed syrian hamster cell line and its metastatic derivatives. Int J Cancer 34: 849-853, 1984
10. Sen S, D'Incaki M: Apoptosis: Biochemical events and relevance to cancer chemotherapy. FEBS Lett 307: 122-127, 1992
11. Darzynkiewicz Z, Kapuscinski J: Acridine orange: a versatile probe of nucleic acids and other cell constituents. In: Melamed MR, Lindmo T, Mendelson L (eds) Flow Cytometry and Sorting, Second Edition, Wiley & Sons, Inc., New York 291-314, 1990
12. Kuzmich S, Tew KD: Detoxification mechanisms and tumor cell resistance to anticancer drugs. Medicinal Research Reviews 2: 185-217. J Wiley & Sons, New York, 1991
13. 1 events and regulation of cell proliferation. Science 246: 603-608, 1989
14. Lennon SV, Martin SJ, Cotter TG: Dose dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif 24: 203-214, 1991
15. Barry MA, Behnke CA, Estman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990
16. Del Bino G, Skierski JS, Darzynkiewisz Z: Diverse effect of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, Molt4) and myelogenous (HL-60, KG1) leukemic cells. Cancer Res 50: 5746-5750, 1990
17. Horwitz SB, Horwitz MS: Effect of camptothecin on the breakage and repair of DNA during cell cycle. Cancer Res 33: 2834-2836, 1973
18. Martin SJ, Cotter TG: Disruption of microtubules induces an endogenous suicide pathway in human leukemia HL-60 cells. Cell and Tissue Kinetics 23: 545-559, 1990
19. Johnson TS, Knight CRL, El-Alaoui S, Mian S, Rees RC, Gentile V, Davies PJA, Griffin M: Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene 9: 2935-2942, 1994
20. Fairchild CR, Maybaum J, Straw J: Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture. Cancer Chemother Pharmacol 22: 26-32, 1988
21. Liu LF: DNA topoisomerase poisons as antitumour drugs. Ann Rev Biochem 58: 351-375, 1989
22. Solary E, Bertrand R, Kohn KW, Pommier Y: Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 5: 1359-1368, 1993
23. Holm C, Covey JM, Kerrigan D, Pommier Y: Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res 50: 6365-6368, 1989
24. Kaufmann SH: Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line. Cancer Res 51: 1129-1136, 1991
25. Hickman JA, Beere HM, Wood AC, Waters CM, Parmar R: Mechanisms of cytotoxicity caused by antitumor drugs. Pharmacol Lett 64/65: 553-561, 1990